Advanced search
1 file | 603.07 KB Add to list

The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model

ISABELLE DEBERGH (UGent) , Nancy Van Damme (UGent) , Piet Pattyn (UGent) , Marc Peeters (UGent) and Wim Ceelen (UGent)
(2010) BRITISH JOURNAL OF CANCER. 102(5). p.837-843
Author
Organization
Keywords
SURVIVAL, METASTASIS, GROWTH, CANCER, HEPARANASE, intravital microscopy, skinfold chamber, angiogenesis, LMWH, nadroparin, CELL-PROLIFERATION, FACTOR PATHWAY INHIBITOR, ADVANCED MALIGNANCY, IN-VITRO, TUBE FORMATION

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 603.07 KB

Citation

Please use this url to cite or link to this publication:

MLA
DEBERGH, ISABELLE et al. “The Low-molecular-weight Heparin, Nadroparin, Inhibits Tumour Angiogenesis in a Rodent Dorsal Skinfold Chamber Model.” BRITISH JOURNAL OF CANCER 102.5 (2010): 837–843. Print.
APA
DEBERGH, I., Van Damme, N., Pattyn, P., Peeters, M., & Ceelen, W. (2010). The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model. BRITISH JOURNAL OF CANCER, 102(5), 837–843.
Chicago author-date
DEBERGH, ISABELLE, Nancy Van Damme, Piet Pattyn, Marc Peeters, and Wim Ceelen. 2010. “The Low-molecular-weight Heparin, Nadroparin, Inhibits Tumour Angiogenesis in a Rodent Dorsal Skinfold Chamber Model.” British Journal of Cancer 102 (5): 837–843.
Chicago author-date (all authors)
DEBERGH, ISABELLE, Nancy Van Damme, Piet Pattyn, Marc Peeters, and Wim Ceelen. 2010. “The Low-molecular-weight Heparin, Nadroparin, Inhibits Tumour Angiogenesis in a Rodent Dorsal Skinfold Chamber Model.” British Journal of Cancer 102 (5): 837–843.
Vancouver
1.
DEBERGH I, Van Damme N, Pattyn P, Peeters M, Ceelen W. The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model. BRITISH JOURNAL OF CANCER. 2010;102(5):837–43.
IEEE
[1]
I. DEBERGH, N. Van Damme, P. Pattyn, M. Peeters, and W. Ceelen, “The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model,” BRITISH JOURNAL OF CANCER, vol. 102, no. 5, pp. 837–843, 2010.
@article{932784,
  author       = {DEBERGH, ISABELLE and Van Damme, Nancy and Pattyn, Piet and Peeters, Marc and Ceelen, Wim},
  issn         = {0007-0920},
  journal      = {BRITISH JOURNAL OF CANCER},
  keywords     = {SURVIVAL,METASTASIS,GROWTH,CANCER,HEPARANASE,intravital microscopy,skinfold chamber,angiogenesis,LMWH,nadroparin,CELL-PROLIFERATION,FACTOR PATHWAY INHIBITOR,ADVANCED MALIGNANCY,IN-VITRO,TUBE FORMATION},
  language     = {eng},
  number       = {5},
  pages        = {837--843},
  title        = {The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model},
  url          = {http://dx.doi.org/10.1038/sj.bjc.6605535},
  volume       = {102},
  year         = {2010},
}

Altmetric
View in Altmetric
Web of Science
Times cited: